A share of BioLife Solutions Inc. (NASDAQ:BLFS) closed at $21.55 per share on Wednesday, up from $21.49 day before. While BioLife Solutions Inc. has overperformed by 0.28%, investors are advised to look at stock chart patterns for technical insight. Within its last year performance, BLFS fell by -52.71%, with highs and lows ranging from $45.85 to $10.40, whereas the simple moving average jumped by 8.87% in the last 200 days.
Do You Own These 7 Inflation-Survival Stocks?
Inflation is still near 40-year highs and rising prices are putting a big dent in our wallets. Unless you find out how to protect your portfolio and outpace inflation, you'll keep being at the mercy of economic factors out of your control. Especially since the price of electricity, food, and shelter are creeping up higher than ever. In this special report, I detail 7 stocks to help you survive and thrive in today's market. They're backed by solid companies, positioned to profit during tough economic times, and offer out-sized dividends to help you outpace inflation.
Click here to get your free copy of the report
On April 25, 2022, Oppenheimer Upgraded BioLife Solutions Inc. (NASDAQ: BLFS) to Outperform. A report published by B. Riley Securities on October 19, 2021, Initiated its previous ‘Buy’ rating for BLFS. Cowen also rated BLFS shares as ‘Outperform’, setting a target price of $64 on the company’s shares in an initiating report dated October 15, 2021. The Benchmark Company March 23, 2021d its ‘Hold’ rating to ‘Buy’ for BLFS, as published in its report on March 23, 2021. KeyBanc Capital Markets’s report from November 10, 2020 suggests a price prediction of $40 for BLFS shares, giving the stock a ‘Overweight’ rating. Oppenheimer also rated the stock as ‘Perform’.
Analysis of BioLife Solutions Inc. (BLFS)
Further, the quarter-over-quarter increase in sales is 20.40%, showing a positive trend in the upcoming months.
BioLife Solutions Inc.’s future performance can be predicted by a variety of well-rounded types of analysis and research, with equity being one of the most crucial ones. The goal here is to ensure that your current return on equity of -23.30% is sufficient for you to turn a profit off your investment. Taking into account the quick ratio of the company, currently set at 2.80, you can see that the company can cover any debts it may have, which can easily be seen in the annual report of the company.
For any stock, average volume can be an extremely valuable indicator of volatility, and BLFS is registering an average volume of 354.71K. On a monthly basis, the volatility of the stock is set at 10.55%, whereas on a weekly basis, it is put at 7.23%, with a loss of -4.98% over the past seven days. Furthermore, long-term investors anticipate a median target price of $31.38, showing growth from the present price of $21.55, which can serve as yet another indication of whether BLFS is worth investing in or should be passed over.
How Do You Analyze BioLife Solutions Inc. Shares?
Besides checking the fundamentals, you should also know how many employees own shares in the company. This is because the values should be in line with investors’ expectations. As such, the current holdings of company stock inside the company are set at 2.70%. This can enable you to see the extent to which executives own the company’s stock. As opposed to executive stock, institutional ownership accounts for 93.70% of the company’s shares, contributing to an indication of company value, since large shareholders may signify strength within the organization.
Are institutional investors increasing their holdings in BLFS shares?
The recent increase in stakes in BLFS appears to be a result of several institutional investors and hedge funds increasing their positions. BlackRock Fund Advisors made another increased to its shares in BLFS during the first quarter, upping its stake by 10.91%. During the last quarter, the company picked up 489,914 additional shares for a total stake of worth $117.11 million, bringing number of shares owned by the company to 4,979,186.
During the first quarter, The Vanguard Group, Inc. added a 312,737 position in BLFS. Fred Alger Management LLC purchased an additional 0.39 million shares in the last quarter, increasing its holdings by 21.90%, now holding 2.16 million shares worth $50.88 million. At the end of the first quarter, Geneva Capital Management LLC increased its BLFS holdings by 5.81% and now holds 1.54 million BLFS shares valued at $36.17 million with the added 84435.0 shares during the period. BLFS shares are owned by institutional investors to the tune of 93.70% at present.